G17DT Terminated Phase 2 Trials for Colorectal Cancers Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02228785A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer